Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation | |
|---|---|---|
| D012128 | Respiratory Distress Syndrome, Adult NIH | 0.07 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Acute respiratory distress syndrome (ARDS) is a type of respiratory failure characterized by the rapid onset of widespread inflammation in the lungs. ARDS is thought to be the main cause of respiratory failure in COVID-19 patients. Research is still ongoing to further elucidate the different ARDS subtypes that may exist in COVID-19. It is crucial to find new targets for treatment and support of COVID-19 patients with respiratory failure.
Description: change in oxygen saturation and PaO2/FiO2 ratio by 20% on day 6 compared to baseline values prior to Iloprost initiation.
Measure: change in oxygenation parameters Time: 5 daysDescription: likelihood to require intubation in the cohort treated with Iloprost
Measure: Rates of endotracheal intubation Time: 28 daysDescription: in days in the cohort treated with Iloprost
Measure: Invasive ventilation duration Time: 28 daysDescription: in days in the cohort treated with Iloprost
Measure: ICU length of stay Time: 28 daysDescription: in days in the cohort treated with Iloprost
Measure: Hospital Length of stay Time: 28 daysDescription: likelihood to require proning in the cohort treated with Iloprost
Measure: Rates of proning therapy Time: 28 daysDescription: likelihood to require ECMO cannulation in the cohort treated with Iloprost
Measure: Rates of ECMO cannulation Time: 28 daysDescription: likelihood to die of any cause within 28 days of initial hospital presentation
Measure: Mortality Time: 28 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports